Developmental Heterogeneity of Pulmonary Endothelial Phenotype at Single Cell Resolution
单细胞分辨率肺内皮表型的发育异质性
基本信息
- 批准号:10211048
- 负责人:
- 金额:$ 70.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:APLN geneATAC-seqAdultAffectAirAir SacsAlveolarAlveolar Cell Type IAppearanceAreaAutomobile DrivingBirthBlood VesselsBronchopulmonary DysplasiaCell ProliferationCellsChronicComplicationCuesDataData SetDevelopmentDiseaseDistalEndothelial CellsEndotheliumExperimental ModelsGasesGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGrowthHeterogeneityHyperoxiaImageImpairmentIn VitroInfantKITLG geneKnockout MiceKnowledgeLifeLigandsLungMediatingMicrocirculationMolecularMusNatural regenerationNeonatal Hyperoxic InjuryOrganPathway interactionsPerinatalPhasePhenotypePopulationPremature BirthProcessResolutionRoleSignal TransductionStimulusSurfaceTestingTimeTransgenic OrganismsTranslatingWorkangiogenesisblood vessel developmentin vivoloss of functionlung developmentlung injurymigrationmouse modelnovelnovel strategiesnovel therapeutic interventionpaternal imprintpostnatalpostnatal developmentprematureprogenitorrapid growthreceptorreceptor expressionresponseself-renewalsingle-cell RNA sequencingstemstem cellstargeted treatmenttranscription factortranscriptomicsvirtual
项目摘要
Postnatal lung growth during alveolarization markedly increases gas exchange surface area. Rapid
growth of the pulmonary vasculature during early alveolarization drives distal lung growth. As alveolarization
slows, the vasculature transitions from a phase of angiogenic growth to quiescence, however the molecular
mechanisms regulating this transition remain poorly defined. This gap in knowledge confounds efforts to develop
targeted therapies to treat diseases of dysregulated angiogenesis and impaired alveolarization, including
bronchopulmonary dysplasia, the most common complication of preterm birth. We recently employed single cell
transcriptomics to define endothelial cell (EC) diversity during postnatal lung development and to identify novel
mechanisms regulating pulmonary angiogenesis and quiescence. Our preliminary data identified a tremendous
increase in EC diversity after birth, marked by the appearance of numerous transcriptionally distinct clusters. A
highly proliferative EC cluster is abundant before birth, virtually disappears just after birth, but peaks again at
early alveolarization, a time of exponential pulmonary angiogenesis. The microvascular EC (MEC) broadly
separated into Car4 expressing (Car4+) and Car4- MEC. In contrast with gradual changes in gene expression
in the Car4+ MEC over time, gene expression changed dramatically in the Car4- MEC, with separation of this
population into two transcriptionally distinct clusters of “early” (P1-P7) and “late” (P21) Car4- MEC. High
expression of the paternally imprinted gene-3 (Peg3), a gene expressed by self-renewing progenitor cells,
distinguished the “early” from the “late” Car4- MEC. Peg3 also enhances NFkB signaling, a pathway we
previously identified as essential for pulmonary angiogenesis during early alveolarization. Of note, the expression
of receptor-ligand pairs suggested that cross-talk stemming from the Car4+ MEC may promote pro-proliferative
and pro-angiogenic signaling in the Car4- MEC. Taken together, our data suggest the overall hypothesis that the
early Car4- MEC represent a specialized, highly proliferative and angiogenic EC population required for the rapid
growth of the pulmonary vasculature during early alveolarization, which will be tested through three specific aims.
Aim 1 will utilize transgenic and cell-specific knock out mice, advanced imaging, and loss of function studies in primary
EC to probe the role of Peg3 in promoting proliferation, angiogenesis and NFkB activation in Car4- MEC. Aim 2 will
use FACS sorted Car4+ and Car4- MEC and a novel mouse model permitting targeting of Car4+ MEC to test if
interaction between these two distinct MEC promotes postnatal angiogenesis. Finally, Aim 3 will employ
computational ligand-receptor analysis, ATAC-Seq, and EC-specific knock out mice to determine if chronic
hyperoxia impairs angiogenesis by impairing Car4- MEC proliferation, Peg3-mediated self-renewal and Car4+
and Car4- MEC cross-talk. The successful completion of these studies will provide a deep view of pulmonary
vascular development at single cell resolution, and identify new pathways that may be translated into novel
strategies to enhance lung growth and regeneration in diseases marked by impaired pulmonary angiogenesis.
出生后肺泡化过程中的肺生长显著增加了气体交换表面积。快速
在早期肺泡化过程中肺脉管系统的生长驱动远端肺生长。肺泡化
当血管生长减慢时,血管系统从血管生成生长的阶段过渡到静止,然而,
管理这一过渡的机制仍然不明确。这种知识上的差距阻碍了发展
治疗血管生成失调和肺泡化受损疾病的靶向疗法,包括
支气管肺发育不良,早产最常见的并发症。我们最近采用了单细胞
转录组学来确定出生后肺发育期间内皮细胞(EC)的多样性,
调节肺血管生成和静止的机制。我们的初步数据显示
出生后EC多样性增加,其特征是出现许多转录上不同的簇。一
高度增殖的EC簇在出生前大量存在,出生后几乎消失,但在出生后再次达到峰值。
早期肺泡化,指数肺血管生成的时间。微血管EC(MEC)广泛
分离为表达Car 4的(Car 4+)和Car 4- MEC。与基因表达的逐渐变化相反,
在Car 4 + MEC中,随着时间的推移,Car 4- MEC中的基因表达发生了显著变化,
群体分成两个转录上不同的簇“早期”(P1-P7)和“晚期”(P21)Car 4- MEC。高
父系印记基因-3(Peg 3)的表达,该基因由自我更新祖细胞表达,
区分“早期”和“晚期”的Car 4- MEC。Peg 3还增强NFkB信号传导,
以前被认为是早期肺泡化过程中肺血管生成所必需的。值得注意的是,
受体-配体对的研究表明,来自Car 4 + MEC的串扰可能促进促增殖
和促血管生成信号。综上所述,我们的数据表明,
早期Car 4- MEC代表了一种特化的、高度增殖的和血管生成的EC群体,
在早期肺泡化过程中肺血管的生长,这将通过三个特定的目标进行测试。
目的1将利用转基因和细胞特异性敲除小鼠,先进的成像,并在初级功能丧失的研究
EC以探测Peg 3在促进Car 4- MEC中的增殖、血管生成和NFkB活化中的作用。目标2将
使用FACS分选的Car 4+和Car 4- MEC以及允许靶向Car 4 + MEC的新型小鼠模型来测试
这两种不同MEC之间的相互作用促进出生后血管生成。最后,目标3将采用
计算配体-受体分析、ATAC-Seq和EC特异性敲除小鼠,以确定慢性
高氧通过损害Car 4- MEC增殖、Peg 3介导的自我更新和Car 4+而损害血管生成
和Car 4- MEC串扰。这些研究的成功完成将提供一个深入了解肺
血管发展在单细胞分辨率,并确定新的途径,可能会转化为新的
在以肺血管生成受损为标志的疾病中增强肺生长和再生的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cristina Maria Alvira其他文献
Cristina Maria Alvira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cristina Maria Alvira', 18)}}的其他基金
Pericytes and postnatal alveolarization: Role of hypoxia inducible factors
周细胞和出生后肺泡化:缺氧诱导因素的作用
- 批准号:
10467727 - 财政年份:2022
- 资助金额:
$ 70.82万 - 项目类别:
Pericytes and postnatal alveolarization: Role of hypoxia inducible factors
周细胞和出生后肺泡化:缺氧诱导因素的作用
- 批准号:
10615235 - 财政年份:2022
- 资助金额:
$ 70.82万 - 项目类别:
Developmental Heterogeneity of Pulmonary Endothelial Phenotype at Single Cell Resolution
单细胞分辨率肺内皮表型的发育异质性
- 批准号:
10678976 - 财政年份:2021
- 资助金额:
$ 70.82万 - 项目类别:
Diverse Homeostatic Roles for Distinct Macrophages in the Developing Lung Vasculature
不同巨噬细胞在发育中的肺血管系统中的多种稳态作用
- 批准号:
10583456 - 财政年份:2021
- 资助金额:
$ 70.82万 - 项目类别:
Diverse Homeostatic Roles for Distinct Macrophages in the Developing Lung Vasculature
不同巨噬细胞在发育中的肺血管系统中的多种稳态作用
- 批准号:
10362528 - 财政年份:2021
- 资助金额:
$ 70.82万 - 项目类别:
Novel pathways regulating calcium mediated contractility in the pregnant uterus
调节妊娠子宫钙介导的收缩性的新途径
- 批准号:
10373975 - 财政年份:2018
- 资助金额:
$ 70.82万 - 项目类别:
Novel pathways regulating calcium mediated contractility in the pregnant uterus
调节妊娠子宫钙介导的收缩性的新途径
- 批准号:
9893885 - 财政年份:2018
- 资助金额:
$ 70.82万 - 项目类别:
Novel Molecular Mechanisms Regulating Postnatal Pulmonary Angiogenesis
调节产后肺血管生成的新分子机制
- 批准号:
8686276 - 财政年份:2014
- 资助金额:
$ 70.82万 - 项目类别:
Novel Molecular Mechanisms Regulating Postnatal Pulmonary Angiogenesis
调节产后肺血管生成的新分子机制
- 批准号:
9265926 - 财政年份:2014
- 资助金额:
$ 70.82万 - 项目类别:
Novel Molecular Mechanisms Regulating Postnatal Pulmonary Angiogenesis
调节产后肺血管生成的新分子机制
- 批准号:
9059764 - 财政年份:2014
- 资助金额:
$ 70.82万 - 项目类别:
相似国自然基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
- 批准号:81802809
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
- 批准号:31802046
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
- 批准号:31801915
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
- 批准号:31871331
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
- 批准号:
10806548 - 财政年份:2023
- 资助金额:
$ 70.82万 - 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
- 批准号:
10210424 - 财政年份:2018
- 资助金额:
$ 70.82万 - 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
- 批准号:
1714070 - 财政年份:2017
- 资助金额:
$ 70.82万 - 项目类别:
Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
- 批准号:
10558379 - 财政年份:2001
- 资助金额:
$ 70.82万 - 项目类别:














{{item.name}}会员




